Results 201 to 209 of about 10,333 (209)

Fexinidazole for the treatment of human African trypanosomiasis

Drugs of Today, 2019
On November 15, 2018, Fexinidazole Winthrop received a positive opinion from the European Medicines Agency (EMA) (under Article 58) for treatment of first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis caused by Trypanosoma gambiense (gHAT) in adults and children 6 years and older and weighing 20 or more kg ...
openaire   +4 more sources

Diamidines for human African trypanosomiasis.

Current opinion in investigational drugs (London, England : 2000), 2011
Aromatic diamidines are potent trypanocides. Pentamidine, a diamidine, has been used for more than 60 years to treat human African trypanosomiasis (HAT); however, the drug must be administered parenterally and is active against first-stage HAT only, prior to the parasites causing neurological deterioration through invasion of the CNS.
Paine, M. F., Wang, M. Z., Generaux, C. N., Boykin, D. W., Wilson, W. D., de Koning H. P.,, Olson, C. A., Pohlig, G., Burri, C., Brun, R., Murilla, G. A., Thuita, J. K., Barrett, M. P., Tidwell, R. R.   +13 more
openaire   +1 more source

The Treatment of Human African Trypanosomiasis

1994
Milord F, Jacques Pépin
openaire   +3 more sources

Human African Trypanosomiasis

2014
Burri, C., Chappuis, F., Brun, R.
openaire   +2 more sources

In the News

Nature Reviews Microbiology, 2004
N. Mattock, J. Jannin, D. Kioy
openaire   +3 more sources

Oral fexinidazole for human African trypanosomiasis

The Lancet, 2018
openaire   +3 more sources

Diagnosis of human African trypanosomiasis.

2004
Büscher, P., Lejon, V.
openaire   +1 more source

Pathogenesis of human African trypanosomiasis.

2004
Victor W. Pentreath, Peter G. E. Kennedy
openaire   +2 more sources

Epidemiology of human African trypanosomiasis.

2004
Susan C. Welburn, Paul G. Coleman, Eric M. Fèvre, M. A. Miles, Ian Maudlin, P. H. Holmes   +5 more
openaire   +2 more sources